Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 13, Issue 32, Pages 3325-3334Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161207782360708
Keywords
mass spectrometric imaging; MALDI MSI; biomarker discovery; SIMS
Categories
Funding
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017940, P30DA018310] Funding Source: NIH RePORTER
- NIDA NIH HHS [DA 018310, P30 DA018310, DA 017940, R01 DA017940] Funding Source: Medline
Ask authors/readers for more resources
Mass spectrometric imaging (MSI) integrates multiple fields of analytical and biomedical research with the goal of generating chemical maps that present the identity and location of the elements, molecules, and molecular complexes that comprise biological structures. Rapid advances in the development of MSI, which include a broad range of sampling and mass spectrometry strategies, allow the increasingly information-rich creation of chemical images of structurally complex tissues, individual cells, and even single chromosomes. Here we describe a variety of MSI techniques available to investigate the nervous system, with particular focus on the capability of MSI to examine both normal and diseased brain function. An important investigative tool, MSI offers tremendous potential in fundamental studies of brain chemistry, localization of pharmaceutical compounds, and the discovery of biomarkers for different neuropathologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available